Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment
Anik Pramanik, Sankar Bhattacharyya
Life Sciences (2022) Vol. 305, pp. 120755-120755
Closed Access | Times Cited: 20

Showing 20 citing articles:

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 127
T cell-derived exosomes in tumor immune modulation and immunotherapy
Qiujun Zhou, Shenyu Wei, Hui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 13
Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Liling Qin, Jianan Wu
Environmental Research (2023) Vol. 239, pp. 116751-116751
Closed Access | Times Cited: 20
E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells
Manman Liang, Zhengui Sun, Xingwu Chen, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 20
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment
Jennifer Cao, Lyndah Chow, Steven Dow
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Myeloid cells are involved in tumor immunity, metastasis and metabolism in tumor microenvironment
Chun Zhang, Ying Song, Huanming Yang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Multi-omics analysis of copper metabolism-related molecular subtypes and risk stratification for osteosarcoma
Yang Zhang, Wenyu Liu, Dayong Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Recent advances in regulatory immune cells: exploring the world beyond Tregs
Peng Shi, Yi Yu, Hongwei Xie, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation
Liu-Xin Zhou, Yizhou Jiang, Xinqiang Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 3
Targeting NETosis: nature’s alarm system in cancer progression
Yixia Liang, Guo Wu, Jiabao Tan, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcoma
Zhao Zhang, Yubo Shi, Zhijie Zhu, et al.
Cancer Science (2022) Vol. 114, Iss. 4, pp. 1240-1255
Open Access | Times Cited: 12
Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies
Diana C. Lopez, Yvette Robbins, Joshua T. Kowalczyk, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Maitake α-glucan promotes differentiation of monocytic myeloid-derived suppressor cells into M1 macrophages
Yuki Masuda, Yoshiaki Nakayama, Ryohei Shimizu, et al.
Life Sciences (2023) Vol. 317, pp. 121453-121453
Closed Access | Times Cited: 5
Shifting phenotype and differentiation of CD11b+Gr.1+ immature heterogeneous myeloid derived adjuster cells support inflammation and induce regulators of IL17A in imiquimod induced psoriasis
Debanjan Sarkar, Anik Pramanik, Dona Das, et al.
Inflammation Research (2024) Vol. 73, Iss. 9, pp. 1581-1599
Closed Access | Times Cited: 1
Interleukin-10 overexpression in 4T1 cells: A gateway to suppressing mammary carcinoma growth
Xiaoqin Wang, Xiaoqian Wang, Dan Wang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113089-113089
Open Access | Times Cited: 1
Enhanced gene transfection ability of sulfonylated low molecular weight PEI and its application in anti-tumor treatment
Xiaoli Tian, Qing Chen, Yue Hu, et al.
Journal of Materials Chemistry B (2024)
Closed Access | Times Cited: 1
Curcumin Enhances the Efficacy of Docetaxel by Promoting Anti-Tumor Immune Response in Head and Neck Squamous Cell Carcinoma
Lili Sun, Xingmei Yao, Jingmei Liu, et al.
Cancer Investigation (2023) Vol. 41, Iss. 5, pp. 524-533
Closed Access | Times Cited: 3
The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
Peng Dong, Yu Yan, Yujun Fan, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21
Open Access | Times Cited: 5
Blockade of Erythropoietin Enhances the Abscopal Effects of Radiotherapy Restraining Lung Metastasis by Inducing an Immunopermissive Tumor Microenvironment
Shin-Yi Liu, Feng‐Chih Kuo, Wan-Zu Liou, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top